Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-26-118034·SMITH-VAN VURST ANDREW
Schedule 13G ownership disclosure
BIOSTEM TECHNOLOGIES INC
Common Stock, $0.001 par value (the "Common Stock") · CUSIP: 090684200
Event date: 2026-09-30
- Filing-level shares
- 3,854,452.00
- Percent of class
- 18.4%
- Andrew Van Vurst
Shares: 3,854,452.00 · Class: 18.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-118034
- Form type
- SCHEDULE 13G
- Filer
- SMITH-VAN VURST ANDREW
- CIK
- CIK 2147206
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership